Free Trial

NeoGenomics (NEO) Competitors

NeoGenomics logo
$10.05 -0.23 (-2.24%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$10.03 -0.02 (-0.20%)
As of 10/17/2025 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEO vs. FTDR, DGNX, DLO, WSC, HRI, HNGE, CARG, WNS, ATHM, and RELY

Should you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include Frontdoor (FTDR), Diginex (DGNX), DLocal (DLO), WillScot (WSC), Herc (HRI), Hinge Health (HNGE), CarGurus (CARG), WNS (WNS), Autohome (ATHM), and Remitly Global (RELY). These companies are all part of the "business services" industry.

NeoGenomics vs. Its Competitors

Frontdoor (NASDAQ:FTDR) and NeoGenomics (NASDAQ:NEO) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Frontdoor has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Frontdoor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Frontdoor$1.84B2.60$235M$3.3919.44
NeoGenomics$660.57M1.97-$78.73M-$0.81-12.41

Frontdoor currently has a consensus target price of $59.75, suggesting a potential downside of 9.33%. NeoGenomics has a consensus target price of $12.56, suggesting a potential upside of 24.93%. Given NeoGenomics' stronger consensus rating and higher probable upside, analysts clearly believe NeoGenomics is more favorable than Frontdoor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Frontdoor
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
NeoGenomics
1 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.38

Frontdoor has a net margin of 13.07% compared to NeoGenomics' net margin of -15.10%. Frontdoor's return on equity of 125.21% beat NeoGenomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Frontdoor13.07% 125.21% 15.65%
NeoGenomics -15.10%-2.72%-1.54%

In the previous week, Frontdoor had 3 more articles in the media than NeoGenomics. MarketBeat recorded 5 mentions for Frontdoor and 2 mentions for NeoGenomics. Frontdoor's average media sentiment score of 1.00 beat NeoGenomics' score of 0.55 indicating that Frontdoor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Frontdoor
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NeoGenomics
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.5% of NeoGenomics shares are held by institutional investors. 1.5% of Frontdoor shares are held by company insiders. Comparatively, 2.4% of NeoGenomics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Frontdoor has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500.

Summary

Frontdoor beats NeoGenomics on 10 of the 16 factors compared between the two stocks.

Get NeoGenomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEO vs. The Competition

MetricNeoGenomicsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.33B$3.40B$6.11B$10.51B
Dividend YieldN/A2.29%5.73%4.81%
P/E Ratio-12.4122.4484.5227.09
Price / Sales1.97477.80607.37219.49
Price / Cash23.4346.5937.1661.22
Price / Book1.4310.4112.246.52
Net Income-$78.73M-$52.47M$3.32B$276.75M
7 Day Performance10.44%2.32%1.25%2.00%
1 Month Performance16.59%11.14%6.28%2.26%
1 Year Performance-25.88%11.15%59.92%35.58%

NeoGenomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEO
NeoGenomics
2.9062 of 5 stars
$10.05
-2.2%
$12.56
+24.9%
-25.6%$1.33B$660.57M-12.412,200News Coverage
FTDR
Frontdoor
3.4899 of 5 stars
$65.20
+1.0%
$59.75
-8.4%
+25.5%$4.70B$1.84B19.232,120Positive News
DGNX
Diginex
N/A$25.70
+3.1%
N/AN/A$4.59BN/A0.0021Short Interest ↓
Gap Down
DLO
DLocal
2.8862 of 5 stars
$14.20
+4.3%
$14.00
-1.4%
+67.9%$4.25B$745.97M29.581,095News Coverage
Analyst Upgrade
Gap Down
WSC
WillScot
4.6375 of 5 stars
$21.75
+0.7%
$32.13
+47.7%
-42.4%$3.93B$2.40B36.254,500News Coverage
HRI
Herc
3.562 of 5 stars
$120.51
+2.3%
$149.20
+23.8%
-27.7%$3.91B$3.57B140.137,600Analyst Forecast
HNGE
Hinge Health
N/A$50.39
+1.2%
$57.47
+14.0%
N/A$3.91BN/A0.001,514
CARG
CarGurus
3.7774 of 5 stars
$33.99
+1.5%
$38.79
+14.1%
+11.0%$3.33B$894.38M27.631,282Analyst Forecast
Insider Trade
WNS
WNS
1.7741 of 5 stars
$76.30
flat
$67.43
-11.6%
+71.9%$3.27B$1.31B21.2564,505News Coverage
Trading Halted
ATHM
Autohome
3.7011 of 5 stars
$26.77
+1.0%
$36.00
+34.5%
-5.6%$3.10B$964.42M15.754,415Positive News
RELY
Remitly Global
3.4255 of 5 stars
$14.85
-0.9%
$27.25
+83.5%
+8.1%$3.09B$1.26B247.542,800Insider Trade

Related Companies and Tools


This page (NASDAQ:NEO) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners